175 related articles for article (PubMed ID: 22292753)
1. RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).
Nagini S
Anticancer Agents Med Chem; 2012 Sep; 12(7):718-25. PubMed ID: 22292753
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
Liu N; Zhou B; Zhu G
Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
Namwat N; Puetkasichonpasutha J; Loilome W; Yongvanit P; Techasen A; Puapairoj A; Sripa B; Tassaneeyakul W; Khuntikeo N; Wongkham S
J Gastroenterol; 2011 May; 46(5):664-75. PubMed ID: 21076843
[TBL] [Abstract][Full Text] [Related]
5. Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries.
Palladini G; Di Pasqua LG; Croce AC; Ferrigno A; Vairetti M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139236
[TBL] [Abstract][Full Text] [Related]
6. The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases.
Alexius-Lindgren M; Andersson E; Lindstedt I; Engström W
Anticancer Res; 2014 Aug; 34(8):3867-73. PubMed ID: 25075007
[TBL] [Abstract][Full Text] [Related]
7. Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer.
Stenzinger A; von Winterfeld M; Rabien A; Warth A; Kamphues C; Dietel M; Weichert W; Klauschen F; Wittschieber D
Hum Pathol; 2012 Aug; 43(8):1314-21. PubMed ID: 22397871
[TBL] [Abstract][Full Text] [Related]
8. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression.
Shen KH; Hung JH; Chang CW; Weng YT; Wu MJ; Chen PS
Chem Biol Interact; 2017 Apr; 268():129-135. PubMed ID: 28283413
[TBL] [Abstract][Full Text] [Related]
9. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
[TBL] [Abstract][Full Text] [Related]
10. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
[TBL] [Abstract][Full Text] [Related]
11. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Liu J; Chi D; Lu H; Zhang T; Yamakawa T
Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Liu N; Cao Y; Zhu G
Arch Oral Biol; 2017 Mar; 75():62-67. PubMed ID: 28043014
[TBL] [Abstract][Full Text] [Related]
13. Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.
Russell JJ; Grisanti LA; Brown SM; Bailey CA; Bender SB; Chandrasekar B
Cell Signal; 2021 Jul; 83():109993. PubMed ID: 33781845
[TBL] [Abstract][Full Text] [Related]
14. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
Clark JC; Thomas DM; Choong PF; Dass CR
Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases.
Mendes SR; Amo-Maestro LD; Marino-Puertas L; Diego I; Goulas T; Gomis-Rüth FX
Sci Rep; 2020 Apr; 10(1):6317. PubMed ID: 32286475
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).
Yoshida D; Nomura R; Teramoto A
J Neurooncol; 2008 Sep; 89(2):141-50. PubMed ID: 18493720
[TBL] [Abstract][Full Text] [Related]
18. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
[TBL] [Abstract][Full Text] [Related]
19. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
20. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.
Zheng WP; Meng FL; Wang LY
Mol Cell Probes; 2020 Oct; 53():101572. PubMed ID: 32525042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
